Reddy's Laboratories Biocon Sandoz Group AG *Disclaimer: Major Players sorted in no particular order Recent Industry Developments July 2026: The EMA Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion recommending authorization of the Wegovy pill (oral semaglutide 25 mg, once-daily) for obesity treatment in the EU, the first oral GLP-1 receptor agonist to receive a CHMP recommendation for weight management, materially broadening Novo Nordisk's European product footprint beyond the injectable-only category
Eating good, regular meals can help keep your blood sugar steady
However, IR and secondary cell dysfunction leading to increasing blood glucose accounts for the majority of cases
Diabetes 54 , 32583264 (2005)
Vitamin injections have become a popular wellness trend in todays health-conscious world
Health Canada Registry: Six Generic Semaglutide Files Pending Health Canada's public submissions registry shows six generic semaglutide applications still under review after the June 29, 2026 Sevmia authorization
